---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297203583.md"
description: "Clinuvel Pharmaceuticals shares are trading lower after the company reported weak FY26 financial results."
datetime: "2026-08-27T14:17:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297203583.md)
  - [en](https://longbridge.com/en/news/297203583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297203583.md)
generator: "portal-rs"
---

# 

Clinuvel Pharmaceuticals shares are trading lower after the company reported weak FY26 financial results.

### Related Stocks

- [CUVL.US](https://longbridge.com/en/quote/CUVL.US.md)
- [CUV.AU](https://longbridge.com/en/quote/CUV.AU.md)

## Related News & Research

- [Clinuvel posts FY2026 net profit after tax of A$34 million, cash reserves rise to A$252 million](https://longbridge.com/en/news/297115070.md)
- [Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)](https://longbridge.com/en/news/297270766.md)
- [CUV: Profit streak continues with robust cash reserves and stable dividend, supporting U.S. growth](https://longbridge.com/en/news/297114798.md)
- [Nika Pharmaceuticals publishes video investor presentation factsheet](https://longbridge.com/en/news/296928069.md)
- [Fennec Pharmaceuticals CFO Robert Andrade sells 75,000 common shares for $883,500](https://longbridge.com/en/news/297371554.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**